Zebra Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-71,071
Closed -$207K 315
2020
Q2
$207K Sell
71,071
-2,879
-4% -$8.39K 0.3% 156
2020
Q1
$208K Sell
73,950
-7,844
-10% -$22.1K 0.34% 137
2019
Q4
$265K Buy
81,794
+7,884
+11% +$25.5K 0.24% 181
2019
Q3
$160K Buy
73,910
+17,999
+32% +$39K 0.17% 198
2019
Q2
$176K Buy
55,911
+25,934
+87% +$81.6K 0.09% 414
2019
Q1
$112K Hold
29,977
0.06% 413
2018
Q4
$87K Sell
29,977
-44,718
-60% -$130K 0.05% 363
2018
Q3
$196K Buy
74,695
+6,803
+10% +$17.9K 0.09% 385
2018
Q2
$159K Sell
67,892
-47,539
-41% -$111K 0.07% 317
2018
Q1
$339K Buy
115,431
+17,654
+18% +$51.8K 0.12% 278
2017
Q4
$268K Sell
97,777
-12,041
-11% -$33K 0.09% 288
2017
Q3
$372K Sell
109,818
-5,865
-5% -$19.9K 0.12% 226
2017
Q2
$286K Sell
115,683
-11,088
-9% -$27.4K 0.09% 236
2017
Q1
$288K Buy
126,771
+55,043
+77% +$125K 0.09% 249
2016
Q4
$152K Sell
71,728
-7,861
-10% -$16.7K 0.05% 260
2016
Q3
$267K Buy
79,589
+12,981
+19% +$43.5K 0.08% 256
2016
Q2
$209K Buy
66,608
+16,410
+33% +$51.5K 0.07% 259
2016
Q1
$167K Hold
50,198
0.07% 247
2015
Q4
$178K Sell
50,198
-5,496
-10% -$19.5K 0.1% 222
2015
Q3
$280K Sell
55,694
-4,642
-8% -$23.3K 0.17% 216
2015
Q2
$388K Buy
60,336
+11,368
+23% +$73.1K 0.23% 203
2015
Q1
$344K Hold
48,968
0.18% 199
2014
Q4
$378K Buy
48,968
+20,121
+70% +$155K 0.15% 218
2014
Q3
$215K Sell
28,847
-1,086
-4% -$8.09K 0.09% 237
2014
Q2
$290K Buy
29,933
+13,348
+80% +$129K 0.11% 229
2014
Q1
$138K Sell
16,585
-176,020
-91% -$1.46M 0.06% 278
2013
Q4
$1.63M Buy
192,605
+40,448
+27% +$341K 0.85% 24
2013
Q3
$1.21M Sell
152,157
-11,827
-7% -$94.3K 0.95% 17
2013
Q2
$1.27M Buy
+163,984
New +$1.27M 1.05% 16